Clinical Relevance of Small Airways Disease in Severe Asthma Patients Treated With Anti-InterLeukin-5 Therapy
NCT05706597 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2023-01-31
Summary
The aim of this research is to investigate the extent and clinical relevance of small airways disease in severe eosinophilic asthma patients treated with anti-IL5/5R therapy.
Conditions
Sponsors & Collaborators
-
Frisius Medisch Centrum
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-02
- Primary Completion
- 2023-03-01
- Completion
- 2023-03-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines
NCT04412044 ·Status: COMPLETED ·Phase: PHASE4
-
Towards Restoring the Physiological Inhibition of Airway Narrowing in Asthma
NCT00279136 ·Status: UNKNOWN
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
NCT00327197 ·Status: TERMINATED ·Phase: PHASE1
-
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
NCT00331292 ·Status: TERMINATED
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671 ·Status: UNKNOWN
-
Effectiveness of Anti-IL-5/IL5R Inhibitors
NCT06239441 ·Status: COMPLETED
-
Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma
NCT00598104 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
NCT02567708 ·Status: COMPLETED ·Phase: PHASE2
-
Develop and Implement Asthma Controlling Strategies (2)
NCT00005733 ·Status: COMPLETED
-
Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion
NCT05787678 ·Status: RECRUITING
-
Efficacy, Safety, and Pharmacokinetics of QAW039
NCT01253603 ·Status: COMPLETED ·Phase: PHASE2
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
Development and Evaluation of Community Asthma Program
NCT00005714 ·Status: COMPLETED
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710 ·Status: COMPLETED ·Phase: NA
-
Poor Response to Monoclonal Therapy in Asthma
NCT04114396 ·Status: UNKNOWN
-
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma
NCT02124226 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Benralizumab on Exercise-induced Bronchoconstriction
NCT03327701 ·Status: UNKNOWN ·Phase: PHASE3
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)
NCT02123667 ·Status: COMPLETED
-
Response and Remission to Treatment With Anti-IL5/IL5R Antagonists
NCT06348173 ·Status: COMPLETED